Keith M. Gottesdiener

2019

In 2019, Keith M. Gottesdiener earned a total compensation of $4.9M as Former President and Chief Executive Officer at RHYTHM PHARMACEUTICALS, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$277,340
Option Awards$4,133,768
Salary$525,934
Total$4,937,042

Gottesdiener received $4.1M in option awards, accounting for 84% of the total pay in 2019.

Gottesdiener also received $277.3K in non-equity incentive plan and $525.9K in salary.

Rankings

In 2019, Keith M. Gottesdiener's compensation ranked 2,239th out of 13,971 executives tracked by ExecPay. In other words, Gottesdiener earned more than 84.0% of executives.

ClassificationRankingPercentile
All
2,239
out of 13,971
84th
Division
Manufacturing
811
out of 5,698
86th
Major group
Chemicals And Allied Products
257
out of 2,197
88th
Industry group
Drugs
208
out of 1,883
89th
Industry
Pharmaceutical Preparations
152
out of 1,395
89th
Source: SEC filing on April 29, 2020.

Gottesdiener's colleagues

We found two more compensation records of executives who worked with Keith M. Gottesdiener at RHYTHM PHARMACEUTICALS in 2019.

2019

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Executive Officer

2019

Nithya Desikan

RHYTHM PHARMACEUTICALS

Chief Commercial Officer

News

In-depth

You may also like